EGENIX, Inc.

Egenix is a privately held, New York-based biotechnology company focused on the development of innovative cancer therapeutics.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Millbrook, NY, USA
  • Currency USD
  • Founded January 2007
  • Employees 10
  • Website egenixinc.com

Company Summary

The company’s therapeutic platform technology consists of small molecule drugs applicable for the treatment and prevention of a broad spectrum of cancers. Our lead compounds inhibit the protein “translation initiation factors” eIF4E and eIF2α, specifically blocking production of multiple cancer promoting proteins and promoting apoptosis (programmed cell death) and upregulation of tumor suppressor genes.

Team

  • Donald C. Fresne
    Founder and CEO

    ■More than 20 years experience in the biotechnology industry
    ■Former Chairman and CEO Texas Chemical and Plastics, Inc.
    ■Former Chairman and CEO - Resorcinol PR, Inc

  • Jedd F. Levine, MD, MBA
    Chief Medical Officer

    ■Managing partner Connecticut Oncology and Hematology, LLC
    ■Former research and clinical fellow and faculty Division of Oncology, Stanford University
    ■MD Harvard Medical School, MBA Columbia Business School

  • Jerry Shipps, Ph.D.
    Director of Drug Development

    ■Over 15 years of experience in drug discovery in pharmaceutical (Schering-Plough, Merck) and biotechnology (NeoGenesis- start up through acquisition) companies
    ■Extensive track record in advancing oncology programs
    ■BS from the University of California Irvine; PhD in Chemistry from M.I.T.

  • Gerhard Wagner, Ph.D.
    Collaborator at Harvard Medical School

    ■Professor of Biological Chemistry and Molecular Pharmacology, Harvard Medical School

  • Nicholas Rossettos, CPA, MBA
    Chief Financial Officer

    ■Former CFO Manhattan Pharmaceuticals, Inc.
    ■Atlantic Technology Ventures, Inc.
    ■BA Princeton University, MBA Northeastern University

  • Nini Amery
    Assistant to CEO

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free